Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

502
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
502
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

675
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
675
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.2K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.2K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

650
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
650
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

452
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
452
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

1.2K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal transplantation in older recipients - results of the DZIF transplant cohort.

BMC geriatrics·2026
Same author

Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus report.

Frontiers in immunology·2026
Same author

Cardiopulmonary resuscitation in donation after brain death donors aged ≥65 years: impact on outcomes after kidney transplantation - a multi-center study.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

An in-depth analysis of the molecular changes induced by short-term calorie restriction before living kidney donation.

npj aging·2026
Same author

Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMT.

Bone marrow transplantation·2026
Same author

Comparison of the Prognostic Value of Three Different Single HLA Based Antibody Detection Assays.

HLA·2026

Related Experiment Video

Updated: Mar 15, 2026

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

14.6K

Renal dysfunction following bone marrow transplantation.

Stephan Kemmner1, Mareike Verbeek2, Uwe Heemann3

  • 1Department of Nephrology, Klinikum rechts der Isar, Technical University Munich, Ismaninger Str. 22, 81675, Munich, Germany.

Journal of Nephrology
|September 4, 2016
PubMed
Summary
This summary is machine-generated.

Bone marrow transplantation (BMT) frequently causes kidney injury, with risks varying by BMT type. Early diagnosis and tailored treatments, especially for thrombotic microangiopathy and graft-versus-host disease, are crucial for patient outcomes.

Keywords:
Acute kidney injuryBone marrow transplantationChronic kidney diseaseHematopoietic stem cell transplantationRenal dysfunction

More Related Videos

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.4K
Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
17:13

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET

Published on: April 28, 2013

17.6K

Related Experiment Videos

Last Updated: Mar 15, 2026

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

14.6K
Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.4K
Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
17:13

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET

Published on: April 28, 2013

17.6K

Area of Science:

  • Nephrology
  • Hematology
  • Oncology

Background:

  • Acute kidney injury and chronic renal dysfunction are significant complications post-bone marrow transplantation (BMT).
  • Renal dysfunction is a major contributor to mortality in BMT recipients.
  • The risk of renal complications is strongly associated with the specific type of BMT performed.

Purpose of the Study:

  • To review the incidence, risk factors, causes, and management strategies for renal dysfunction following BMT.
  • To emphasize the importance of BMT type as a primary determinant of renal risk.
  • To highlight BMT-specific causes of kidney injury and their therapeutic implications.

Main Methods:

  • Review of literature on renal complications after bone marrow transplantation.
  • Analysis of risk factors, including BMT type, patient age, comorbidities, and baseline creatinine.
  • Categorization of renal failure causes into general (chemotherapy, sepsis, nephrotoxic drugs) and BMT-specific (infusion toxicity, VOD, TMA, GvHD).

Main Results:

  • Myeloablative allogeneic BMT carries the highest risk of renal dysfunction, followed by non-myeloablative allogeneic and myeloablative autologous BMT.
  • BMT type is a more significant risk factor than age, comorbidities, or baseline serum creatinine.
  • Multiple factors contribute to renal failure, including chemotherapy, radiation, fluid loss, sepsis, nephrotoxic agents, marrow infusion toxicity, VOD, TMA, and GvHD.

Conclusions:

  • Therapeutic approaches for renal damage post-BMT depend on the underlying cause.
  • Immunosuppressive therapy is critical for managing TMA and GvHD.
  • Plasma exchange or eculizumab may be indicated for TMA involving the complement system.
  • Referral to tertiary centers is recommended for prompt diagnosis and management of complex renal complications.